Stocks

Why Celestica Inc. stock is plummeting today

By Wealth Awesome Newsroom -
Stocks & ETFs:CLS.TO

Get CLS alerts:

Photos provided by Pexels

Celestica Inc. (CLS.TO) is seeing a notable drop in its share price, which is raising concerns among investors.

Shares of Celestica Inc. (CLS.TO) have fallen sharply in today’s trading session, down 6.52% to CA$440.22. This decline comes as the company prepares to release its quarterly earnings report, leaving investors anxious about potentially disappointing results.

Advertisement

Qtrade Direct Investing

Get up to $2,000 cash back

Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.

Celestica Inc.

CLS.TO

Full stock page →

CLS.TO

Celestica Inc.

Source:WealthAwesomeWealthAwesome
$81.08 (20.80%)
120 day period
$339.51$496.17$652.82Feb 2Apr 29Jul 23

Market cap

$54.39B

P/E

40.4x

52W high

$655.50

52W low

$225.10

1W change

+10.29%

Beta

1.51

Analyst Price Targets

Based on analyst covering CLS

📈

Wall Street analysts forecast CLS stock price to rise 43.9% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$677.41

+43.9% Upside

Current Price

C$470.91

Last close

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on CLS's historical volatility

HistoricalForecast68%95%
C$185.39C$356.34C$527.30C$698.25C$869.21C$1040.16TodayMar 17May 21Jul 23Sep 4Oct 18Nov 30

30-Day Vol

69.6%

Annualized

90-Day Vol

79.8%

Annualized

Trend (90d)

-19.4%

Annualized drift

90d Mean

C$439.32

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$460.14C$361.86C$585.11
60 trading daysC$449.61C$320.08C$631.55
90 trading daysC$439.32C$289.76C$666.08

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Investor takeaway: Investors should remain cautious as Celestica's stock faces downward pressure ahead of its earnings announcement, especially given the broader market context.

Celestica Inc. shares drop 6.52% today

The stock's market cap now stands at CA$54.39 billion, showcasing its significant presence in the electronics manufacturing sector despite recent volatility.

Bull case

Despite today’s drop, Celestica has shown impressive growth over the past year, with a gain of 104.6%. If the earnings report meets or exceeds expectations, it could help reverse today’s losses.

Bear case

The 6.52% decline today reflects investor anxiety about the upcoming earnings report. Analysts project strong year-over-year growth, but it may not be enough to satisfy market expectations.

Market Reaction to Earnings Anticipation

The significant drop in Celestica's stock price today is largely due to investor nervousness ahead of its earnings report scheduled for July 27, 2026. Analysts expect earnings per share of CA$2.29, indicating strong year-over-year growth. However, any failure to meet these expectations could worsen today’s losses.

Comparative Performance in the Tech Sector

Celestica's decline stands out against the broader technology sector, which has seen mixed performance. While some tech stocks are thriving, Celestica's recent struggles highlight the challenges it faces, especially as it prepares to report earnings amid heightened market scrutiny. Investors should weigh the company’s long-term growth potential against today’s volatility.

Looking Ahead: What Investors Should Watch

As Celestica approaches its earnings release, investors should keep an eye on both the earnings figures and any guidance from management about future performance. The company’s ability to navigate current market conditions and meet growth expectations will be crucial in determining the stock's direction after the earnings report.


Advertisement

Sponsored links

Advertisement